BioCatalyst

Lutikizumab — catalyst calendar

2 verified catalyst event(s) referencing Lutikizumab, each linked to its official source. Verified as of 2026-11-05.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 26d
ESTIMATED
 READOUT
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adoles
Phase 3 · Hidradenitis Suppurativa
 ABBV AbbVie Inc. Lutikizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-11-05
Sponsor-projected date — can change
2027-02 (month)
in 3mo
ESTIMATED
 READOUT
A Study to Assess Molecular Changes in Adult Participants With Moderate to Sever
Phase 2 · Hidradenitis Suppurativa, Atopic Dermatitis
 ABBV AbbVie Inc. Lutikizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-11-05
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.